2013 annual financial data
GT Biopharma 2013 Operating margin
GT Biopharma 2013 operating margin with verified reported values.
Direct answer
Operating margin was -215.49%.
Operating income was -793,000 USD and net income was -501,000 USD.
Operating cash flow was -442,000 USD.
Get free GT Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 368,000 USD
- Operating income
- -793,000 USD
- Net income
- -501,000 USD
- Operating cash flow
- -442,000 USD